ANDA Pre-Submission Meetings A 'Challenge' To Integrate Into Development Timelines
US FDA officials appears worried about workload created by product development and pre-submission meetings for complex generics.
US FDA officials appears worried about workload created by product development and pre-submission meetings for complex generics.